Pacer Advisors
EBS icon

Pacer Advisors’s Emergent Biosolutions EBS Stock Holding History

Pacer Advisors’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7K Sell
792
-415,399
-100% -$3.48M ﹤0.01% 2376
2026
Q1 		$3.45M Buy
+416,191
New +$4.31M 0.01% 726
2025
Q4 		– Sell
-536,655
Closed -$4.73M – 3822
2025
Q3 		$4.73M Sell
536,655
-20,075
-4% -$156K 0.01% 725
2025
Q2 		$3.55M Buy
+556,730
New +$3.19M 0.01% 824
2024
Q3 		– Sell
-75
Closed -$512 – 2601
2024
Q2 		$512 Buy
75
+15
+25% +$65 ﹤0.01% 3741
2024
Q1 		$152 Hold
60
– – ﹤0.01% 3688
2023
Q4 		$144 Sell
60
-15
-20% -$35 ﹤0.01% 3519
2023
Q3 		$255 Hold
75
– – ﹤0.01% 2620
2023
Q2 		$551 Buy
75
+5
+7% +$46 ﹤0.01% 3521
2023
Q1 		$725 Hold
70
– – ﹤0.01% 2171
2022
Q4 		$827 Sell
70
-265,096
-100% -$4.1M ﹤0.01% 3302
2022
Q3 		$5.57M Buy
265,166
+265,054
+236,655% +$7.38M 0.04% 344
2022
Q2 		$3K Hold
112
– – ﹤0.01% 2325
2022
Q1 		$5K Sell
112
-27
-19% -$1.19K ﹤0.01% 2259
2021
Q4 		$6K Sell
139
-5,071
-97% -$229K ﹤0.01% 2178
2021
Q3 		$261K Sell
5,210
-1,595
-23% -$96.6K ﹤0.01% 1292
2021
Q2 		$429K Buy
6,805
+713
+12% +$45.8K 0.01% 1181
2021
Q1 		$566K Sell
6,092
-678
-10% -$69.4K 0.01% 1004
2020
Q4 		$607K Sell
6,770
-5,225
-44% -$480K 0.01% 894
2020
Q3 		$1.24M Buy
11,995
+11,943
+22,967% +$1.29M 0.03% 615
2020
Q2 		$4K Buy
+52
New +$3.88K ﹤0.01% 929
2019
Q1 		– Sell
-11,567
Closed -$686K – 751
2018
Q4 		$686K Buy
11,567
+8,454
+272% +$545K 0.02% 109
2018
Q3 		$205K Buy
+3,113
New +$182K 0.01% 1026
2018
Q2 		– Sell
-1,178
Closed -$62K – 1177
2018
Q1 		$62K Buy
1,178
+503
+75% +$25.1K ﹤0.01% 955
2017
Q4 		$31K Buy
+675
New +$28.4K ﹤0.01% 1062

Other funds holding EBS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
OHA
Oak Hill Advisors New York $701M AUM 78.4% 1-Year Est. Return

Pacer Advisors's EBS Position: Q2 2026 in Review

Pacer Advisors reduced its Emergent Biosolutions (EBS) stake by 100% in Q2 2026, selling an estimated $3.48M and leaving 792 shares worth $7K. The position accounts for ﹤0.01% of the portfolio, ranked #2376.

Pacer Advisors first reported a position in EBS in Q4 2017 and has held it in 25 quarters since. The position peaked at $5.57M in Q3 2022. 195 funds tracked by Wall St. Rank hold EBS as of Q2 2026.

  • Pacer Advisors held 792 shares of Emergent Biosolutions worth $7K as of Q2 2026.
  • Pacer Advisors sold 415,399 Emergent Biosolutions shares in Q2 2026, an estimated $3.48M.
  • Emergent Biosolutions made up ﹤0.01% of Pacer Advisors's portfolio in Q2 2026, its #2376 holding.
  • Pacer Advisors first reported a position in Emergent Biosolutions in Q4 2017 and has held it in 25 quarters since.
  • Pacer Advisors's Emergent Biosolutions position peaked at $5.57M in Q3 2022.
  • 195 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2026.

Based on Pacer Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.